Physician

Joseph Kern Weidner, M.D.

According to 2025 Medicare claims, Joseph Weidner, M.D. (NPI: 1659367829) practices family practice in the Wilmington, DE-MD-NJ market, with the plurality of this provider's patient population coming from Cecil, MD. This provider's primary affiliated billing organization is JOSEPH K. WEIDNER JR MD LLC (NPI: 1215117767; TIN: 752978623) and primary practice location at 21911-2272. Weidner is affiliated with the Aledade 80 DelMar MSSP Enhanced (ACO ID: A4856), participating under the MSSP model.

Weidner's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 629 traditional Medicare patients, billed 6,514 HCPCS/CPT codes, and received $280,594 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 10,381 prescription claims across 635 beneficiaries totaling $1,288,764 in drug costs, led by Ingrezza (Valbenazine Tosylate). DME data shows 400 claims. Open Payments data shows 13 records totaling $276. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $585,774 to $1,288,764. In contrast, DME billing represents a smaller volume and rose steadily, from $16,390 to $29,898.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	668	5,714	$293,629
2016	716	6,303	$314,207
2017	711	6,195	$297,728
2018	654	5,451	$245,407
2019	659	5,391	$238,030
2020	681	5,124	$198,717
2021	778	5,848	$253,949
2022	662	6,154	$238,828
2023	615	5,927	$249,620
2024	629	6,514	$280,594

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	491	9,221	$585,774
2016	520	9,031	$578,495
2017	538	9,700	$668,240
2018	551	9,737	$737,067
2019	536	9,044	$688,964
2020	537	9,143	$746,681
2021	570	8,721	$740,175
2022	603	9,770	$975,806
2023	566	9,449	$1,213,075
2024	635	10,381	$1,288,764

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	106	558	$16,336
2016	136	469	$6,433
2017	99	413	$7,096
2018	86	345	$5,971
2019	102	394	$8,567
2020	121	577	$26,226
2021	83	387	$11,795
2022	34	389	$14,386
2023	44	358	$18,167
2024	72	400	$22,354

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	329	329	$132
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	535	1,332	$53
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	241	342	$49
G0442	Annual alcohol misuse screening, 5 to 15 minutes	388	388	$19
G0444	Annual depression screening, 5 to 15 minutes	331	331	$19

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ingrezza	Valbenazine Tosylate	11	330	$167,145
Jardiance	Empagliflozin	148	7,878	$147,991
Eliquis	Apixaban	86	4,753	$97,896
Otezla	Apremilast	12	600	$93,948
Ozempic	Semaglutide	51	2,478	$78,897

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	32	$8,754
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	55	$4,026
A7031	Face mask interface, replacement for full face mask, each	N	N/R	22	$1,992
A7030	Full face mask used with positive airway pressure device, each	N	N/R	22	$1,869
E0601	Continuous positive airway pressure (cpap) device	Y	N/R	37	$1,032

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	13	$276	Merck Sharp & Dohme LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Joseph Kern Weidner, M.D.?

Tedicare shows public-source Medicare data for Joseph Kern Weidner, M.D. (NPI 1659367829), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Joseph Kern Weidner, M.D. have ACO affiliation data?

Joseph Kern Weidner, M.D. is shown with ACO affiliation data for Aledade 80 DelMar MSSP Enhanced (MSSP, ACO ID A4856).

What billing organization is linked to Joseph Kern Weidner, M.D.?

Joseph Kern Weidner, M.D. is linked to JOSEPH K. WEIDNER JR MD LLC (billing NPI 1215117767) in the available physician profile data.

Does Joseph Kern Weidner, M.D. have Open Payments data?

Joseph Kern Weidner, M.D. has 13 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.